EyePoint, Inc. - EYPT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 3.8% | 3,142,437 | View |
| May 15, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 3.8% | 3,142,437 | View |
| May 15, 2026 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 3.8% | 3,142,437 | View |
| May 15, 2026 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 3.3% | 2,769,062 | View |
| May 13, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 3.96% | 3,300,000 | View |
| May 13, 2026 | SCHEDULE 13G/A | Robert Atchinson | 3.96% | 3,300,000 | View |
| May 13, 2026 | SCHEDULE 13G/A | Phillip Gross | 3.96% | 3,300,000 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 24, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 5.1% | 4,192,261 | View |
| Feb 24, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 5.1% | 4,192,261 | View |
| Feb 24, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 5.1% | 4,192,261 | View |
| Feb 24, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 4.5% | 3,694,542 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TCG Crossover GP II, LLC | 4.3% | 3,572,335 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TCG Crossover Fund II, L.P. | 4.3% | 3,572,335 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Chen Yu | 4.3% | 3,572,335 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.68% | 4,700,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 5.68% | 4,700,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 5.68% | 4,700,000 | View |
| Dec 08, 2025 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 9.98% | 8,265,000 | View |
| Dec 08, 2025 | SCHEDULE 13G/A | Chen Bihua | 9.98% | 8,265,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.